Stanley T. Crooke, M.D., Ph.D., Founder, Chairman and CEO of n-Lorem, Presented With the 2022 Roy Vagelos Pro Bono Humanum Award for Global Health Equity
November 1, 2022
n-Lorem founder, chairman, and CEO, Stanley T. Crooke, M.D., Ph.D. was presented with the 2022 Roy Vagelos Pro Bono Humanum Award for Global Health Equity of the Prix Galien.
This award recognizes Dr. Crooke’s nearly 50 years of dedication to a novel, clinically endorsed concept of using synthetic oligonucleotides to control the expression of genes and proteins that impact disease. Dr. Crooke is also recognized for his leadership in being among the first in industry to make a commitment to open science a key element of the modern R&D enterprise and to embrace the principle that even patients with the rarest of afflictions deserve the best talent and expertise the R&D industry can offer.
The Roy Vagelos Pro Bono Humanum Award for Global Health Equity of the Prix Galien USA is given each year to an individual or institution that has helped to improve the human condition in extraordinary ways. The award, which is selected by a committee of distinguished scientists and Nobel laureates, recognizes innovative individual and group efforts to improve the human condition through the application of biomedical science to health problems in developing or underserved populations worldwide. Past winners include Bill Clinton, Dr. Francis Collins, Jimmy Carter, Bill and Melinda Gates and Jim and Marilyn Simons.
Congratulations, Dr. Crooke!
Stanley Crooke, M.D., Ph.D., receives the 2022 Roy Vagelos Pro Bono Humanum Award
We cannot do
Together we are changing the world—
one patient at a time
We hope that you join us on this journey to discover, develop and provide individualized antisense medicines for free for life for nano-rare patients. The ultimate personalized medicine approach – for free, for life.
Follow us on social for updates on our latest efforts